You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,463,740


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,463,740 protect, and when does it expire?

Patent 10,463,740 protects TOLSURA and is included in one NDA.

This patent has eighteen patent family members in ten countries.

Summary for Patent: 10,463,740
Title:Itraconazole compositions and dosage forms, and methods of using the same
Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.
Inventor(s): Mudge; Stuart James (Northcote, AU), Hayes; David (Rostrevor, AU), Lukas; Stefan (Manningham, AU)
Assignee: MAYNE PHARMA INTERNATIONAL PTY. LTD. (Salisbury South, AU)
Application Number:16/198,645
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,463,740: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 10,463,740, providing a detailed analysis of its scope, claims, and the broader patent landscape.

Understanding Patent Scope and Claims

Before diving into the specifics of Patent 10,463,740, it is essential to understand what patent scope and claims entail.

Patent Scope

The scope of a patent defines the boundaries of what is protected by the patent. It is determined by the claims, which are the legally binding descriptions of the invention. The scope can be influenced by various factors, including the language used in the claims, prior art, and the prosecution history of the patent[3].

Patent Claims

Patent claims are the heart of a patent, outlining what the inventor considers to be their invention. They must be clear, concise, and supported by the patent's specification. Claims can be independent or dependent, with dependent claims building upon independent claims[5].

Patent 10,463,740: Overview

To analyze Patent 10,463,740, we need to look at its title, abstract, and the claims themselves.

Title and Abstract

The title and abstract provide a preliminary understanding of the invention. For example, if the patent is titled "Method and System for [Specific Invention]," the abstract will give a brief summary of what the invention entails and its key features.

Claims Analysis

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. These claims are critical because they set the broadest boundaries of what is protected.

Dependent Claims

Dependent claims build upon independent claims, adding additional limitations or features. These claims are narrower and provide further specificity to the invention.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This involves analyzing the claim language, the specification, and the prosecution history to determine the scope of the claims. This process is crucial in patent litigation and can significantly impact the validity and enforceability of the patent[5].

Patent Landscape Analysis

Prior Art

Prior art refers to existing knowledge and inventions that predate the filing of the patent. Analyzing prior art helps in understanding how the invention differs from what already exists and whether the claims are novel and non-obvious.

Competing Patents

Identifying competing patents in the same field can provide insights into the competitive landscape. This involves searching patent databases such as those provided by the USPTO, EPO, JPO, and WIPO[4].

Tools and Resources for Analysis

USPTO Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching existing patents and published patent applications. It replaces older tools like PubEast and PubWest and offers enhanced access to prior art[4].

Global Dossier

The Global Dossier service allows users to view the file histories of related applications from participating IP offices. This can be useful in understanding the global patent family and any office actions related to the patent[4].

Common Citation Document (CCD)

The CCD consolidates prior art cited by multiple patent offices, providing a single point of access to citation data. This is particularly useful for international patent applications[4].

Geographical and Economic Analysis

County-Level Patent Data

For patents like 10,463,740, analyzing county-level patent data can provide insights into regional innovation trends. The USPTO provides such data, which can be analyzed based on the location of the inventor or the patent owner[1].

Economic Impact

Understanding the economic sector of the patent owner can also provide context. For instance, patents owned by companies in specific sectors can indicate industry trends and areas of significant innovation[1].

Legal Considerations

Presumption of Validity

Each claim of a patent is presumed valid, but this presumption can be challenged through various defenses, such as prior art, obviousness, or lack of enablement[5].

Small Claims Patent Court

The concept of a small claims patent court, as studied by ACUS, could impact how patent disputes are resolved, especially for smaller inventors and businesses. This could affect the enforcement and litigation landscape for patents like 10,463,740[2].

Case Studies and Expert Insights

Expert Opinions

Industry experts and legal practitioners often provide valuable insights into patent strategies and the implications of patent claims. For example, experts like Andrei Iancu, former Undersecretary of Commerce for IP and Director of the USPTO, can offer perspectives on patent policy and its impact on innovation[2].

Real-World Applications

Understanding how patents are applied in real-world scenarios can help in analyzing their scope and claims. This includes looking at how the invention is used, any licensing agreements, and how it interacts with other technologies.

Key Takeaways

  • Patent Scope and Claims: The scope is defined by the claims, which must be clear and supported by the specification.
  • Tools and Resources: Utilize USPTO tools like Patent Public Search, Global Dossier, and CCD for comprehensive analysis.
  • Geographical and Economic Analysis: Analyze county-level data and economic sectors to understand regional innovation trends.
  • Legal Considerations: Understand the presumption of validity and potential legal challenges.
  • Expert Insights: Consider opinions from industry experts and legal practitioners.

FAQs

Q: How do I search for existing patents related to my invention?

A: Use the USPTO's Patent Public Search tool or other international patent databases like the EPO, JPO, and WIPO to search for existing patents and published patent applications[4].

Q: What is the difference between independent and dependent claims?

A: Independent claims stand alone and define the invention broadly, while dependent claims build upon independent claims, adding additional limitations or features[5].

Q: How can I determine the scope of a patent claim?

A: Analyze the claim language, the specification, and the prosecution history to determine the scope of the claims[5].

Q: What is the Global Dossier service, and how is it useful?

A: The Global Dossier service provides access to the file histories of related applications from participating IP offices, allowing users to view the global patent family and any office actions related to the patent[4].

Q: Why is it important to analyze prior art when evaluating a patent?

A: Analyzing prior art helps in understanding how the invention differs from existing knowledge and whether the claims are novel and non-obvious.

Sources

  1. National Science Foundation. Invention, Knowledge Transfer, and Innovation. 2022.
  2. Administrative Conference of the United States. U.S. Patent Small Claims Court. 2022.
  3. United States Patent and Trademark Office. Patent Claims Research Dataset. 2017.
  4. United States Patent and Trademark Office. Search for patents - USPTO. 2018.
  5. U.S. House of Representatives. 35 USC 282: Presumption of validity; defenses. 1994.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,463,740

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mayne Pharma TOLSURA itraconazole CAPSULE;ORAL 208901-001 Dec 11, 2018 RX Yes Yes 10,463,740 ⤷  Subscribe Y TREATMENT OF FUNGAL INFECTIONS, INCLUDING BLASTOMYCOSIS, HISTOPLASMOSIS, AND ASPERGILLOSIS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,463,740

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Australia2012902624Jun 21, 2012

International Family Members for US Patent 10,463,740

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013278001 ⤷  Subscribe
Australia 2018201298 ⤷  Subscribe
Australia 2020217438 ⤷  Subscribe
Brazil 112014031706 ⤷  Subscribe
Canada 2876909 ⤷  Subscribe
China 104507480 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.